Search

Your search keyword '"Giuseppe Montalto"' showing total 271 results

Search Constraints

Start Over You searched for: Author "Giuseppe Montalto" Remove constraint Author: "Giuseppe Montalto" Topic humans Remove constraint Topic: humans
271 results on '"Giuseppe Montalto"'

Search Results

1. Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry

2. Hepatocellular Carcinoma: A Difficult Cancer to Treat

3. The Changing Epidemiology of Hepatocellular Carcinoma : Experience of a Single Center

4. New landscapes and horizons in hepatocellular carcinoma therapy

5. Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53

6. Relation between drug therapy-based comorbidity indices, Charlson's comorbidity index, polypharmacy and mortality in three samples of older adults

7. Response to the Letter to the editor regarding 'Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma' by Jiong Lin

8. Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma

9. NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response

10. Comorbidities impact and de-prescribing in elderly with HCV-related liver disease: analysis of a prospective cohort

11. Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients

12. What changed in the Italian internal medicine and geriatric wards during the lockdown

13. Initiation of Psycholeptic Medication During Hospitalization With Recommendation for Discontinuation After Discharge

14. Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients

15. Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53

16. Comparison between drug therapy-based comorbidity indices and the Charlson Comorbidity Index for the detection of severe multimorbidity in older subjects

17. GSK-3? Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals

18. Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis

19. Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines

20. Targeting GSK3 and Associated Signaling Pathways Involved in Cancer

21. An overview of statin-induced myopathy and perspectives for the future

22. Cancer therapy and treatments during COVID-19 era

23. Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling

24. Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53

25. GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms

26. Rivaroxaban-induced hepatotoxicity

27. The Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement?

28. Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation

29. Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs

30. Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells

31. Altilix

32. Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients

33. Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people

34. Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells

35. RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma

36. Inappropriate prescription of benzodiazepines in acutely hospitalized older patients

37. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids

38. Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals

39. Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells

40. Potential Uses of Olive Oil Secoiridoids for the Prevention and Treatment of Cancer: A Narrative Review of Preclinical Studies

41. The effect of bergamot on dyslipidemia

42. In vivo triglyceride synthesis in subcutaneous adipose tissue of humans correlates with plasma HDL parameters

43. Incretins, Pregnancy, and Gestational Diabetes

44. GSK-3 in liver diseases: Friend or foe?

45. Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study

46. Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells

47. Serum lipoproteins are not associated with the severity of asthma

48. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

49. Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals

50. Pancreatic cancer: risk and preventive factors

Catalog

Books, media, physical & digital resources